Skip to main content
OpenTrials

Clinical trial condition

Burkitt Lymphoma

Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.

701 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Burkitt Lymphoma trial results

Recruiting

Study of YK012 in B-cell Acute Lymphoblastic Leukemia

NCT06580301

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
View Trial Details
Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04260022

Conditions
B Cell Precursor Type Acute Leukemia, Blast Crisis, Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Augusta Cancer Center Augusta, Georgia, United States
View Trial Details
Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

NCT03595917

Conditions
B-cell Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Burkitt Lymphoma, +27 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details

Related conditions